Ranked among the top gynecology programs by U.S. News & World Report
Duke’s expert gynecologists draw on the latest developments to treat uterine fibroids, which are growths of tissue found on the wall of the uterus.
Most uterine fibroids are harmless, non-cancerous tumors, and they affect 30 to 40 percent of premenopausal women and 70 to 80 percent of women at age 50.
However, you may need to have them removed or reduced if you experience:
Duke offers a full range of services for uterine fibroid diagnosis and treatment. Early detection may be critical for fertility success, so our physicians use diagnostic tools such as ultrasound, saline infusion sonography, and MRI to detect and locate fibroids.
Current medical therapies for fibroid management are limited. Drugs that reduce estrogen production, such as Lupron and Zoladex, have been found to be the most effective.
The Duke Center for Uterine Fibroid Biology and Therapy is continually researching new drug therapies to treat uterine fibroids. The center comprises physician investigators, basic scientists, and epidemiologists, and it has been a leader in developing new understanding of uterine fibroids.
Traditional treatments for uterine fibroids have included hysterectomy (surgical removal of the uterus) and myomectomy (surgical removal of individual fibroids).
However, Duke is at the forefront of new minimally invasive and non-invasive treatments. Such treatments can reduce recovery time and complications in qualified patients. They include:
For more information about MRI-guided focused ultrasound and other treatments available at Duke, contact email@example.com.
For more information or to schedule an appointment, call 919-684-2471. To find a physician or get a referral, call 888-ASK-DUKE (888-275-3853).
Physicians offering this service include:
This service is available at: